Table 1.
Baseline characteristics of patients.
| Characteristics of patients (n = 510) | Frequency (%) |
|---|---|
| Median age (interquartile range) | 35 (25–50) |
| Age groups, y | |
| 0–29 | 190 (37.3) |
| 30–44 | 148 (29.0) |
| 45–59 | 83 (16.3) |
| ≥60 | 89 (17.5) |
| Sex | |
| Male | 321 (62.9) |
| Female | 189 (37.1) |
| Area of residence | |
| Urban | 248 (48.6) |
| Rural | 262 (51.4) |
| Type of illness | |
| New cases (Category I) | 395 (77.5) |
| Re-treatment cases (Category II) | 115 (22.5) |
| Relapse | 49 (9.6) |
| Treatment failure | 1 (0.2) |
| Treatment after default | 12 (2.4) |
| Retreatment others | 53 (10.4) |
| Site of disease | |
| Pulmonary | 383 (75.1) |
| Sputum positive | 233 (45.7) |
| Sputum negative | 150 (29.4) |
| Extrapulmonary | 127 (24.9) |
| HIV status | |
| Negative | 446 (87.5) |
| Positive | 35 (6.9) |
| On ART | 24 (4.7) |
| Not on ART | 11 (2.2) |
| Unknown | 29 (5.7) |
| Diabetic status | |
| Diabetic | 12 (2.4) |
| Non-diabetic | 187 (36.7) |
| Unknown | 311 (61.0) |
| Treatment interruption leading to prolonged treatment duration | |
| Category I patients (n = 327) | |
| 24–28 wks | 237 (72.5) |
| 28–32 wks | 55 (16.8) |
| >32 wks | 35 (10.7) |
| Category II patients (n = 76) | |
| >32 wks | 76 (100) |
ART = antiretroviral therapy.